Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure.

BACKGROUND Factors implicated in the severity of drug reaction with eosinophilia and systemic symptoms (DRESS) have not been identified. We retrospectively describe and analyze severe cases of DRESS defined by history of intensive care unit admission and death due to DRESS. OBSERVATIONS Of 15 patients retrospectively recruited in France, 14 were admitted to the intensive care unit and 3 died. The culprit drugs were already known to cause or trigger DRESS: allopurinol, minocycline hydrochloride, anticonvulsants, sulfonamides, and antibiotics. Visceral involvement with severe manifestations responsible for intensive care unit admission or death was variable and often multiple (pneumonitis, hepatitis, renal failure, encephalitis, hemophagocytosis, cardiac failure, and pancytopenia) and resulted in multiorgan failure in 11 patients. These severe complications sometimes developed late in DRESS. Human herpesvirus 6 infection was demonstrated in 6 of 7 patients. In addition, human herpesvirus 6 infection was demonstrated in involved viscera in 2 patients. CONCLUSIONS Severe DRESS is rare. Some specificities of visceral involvement were associated with allopurinol and minocycline. However, visceral involvement comprising multiorgan failure seemed to be unpredictable. Better knowledge of DRESS is necessary to propose specific and prompt treatment. Early demonstration of human herpesvirus 6 reactivation could be considered a prognostic factor for identifying patients at higher risk and, hence, needs to be evaluated.

[1]  M. Tohyama,et al.  Association of human herpesvirus 6 reactivation with the flaring and severity of drug‐induced hypersensitivity syndrome , 2007, The British journal of dermatology.

[2]  P. Schnitzler,et al.  Fatal circumstances of human herpesvirus 6 infection: transcriptosome data analysis suggests caution in implicating HHV-6 in the cause of death , 2007, Journal of Clinical Pathology.

[3]  Z. Ikezawa,et al.  The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations , 2007, The British journal of dermatology.

[4]  V. Descamps,et al.  Augmentation de la réplication in vitro de l’herpèsvirus humain 6 en présence de valproate de sodium , 2007 .

[5]  D. Zerr Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  O. Boccara,et al.  Association of hypogammaglobulinemia with DRESS (Drug Rash with Eosinophilia and Systemic Symptoms). , 2006, European journal of dermatology : EJD.

[7]  M. Seishima,et al.  Hypogammaglobulinemia as an early sign of drug-induced hypersensitivity syndrome. , 2006, Journal of the American Academy of Dermatology.

[8]  P. Demoly,et al.  Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? , 2006, The British journal of dermatology.

[9]  E. Mahé,et al.  Systemic Reactions to HHV-6 Infection , 2006 .

[10]  G. Krueger,et al.  Human herpesvirus-6 : general virology, epidemiology and clinical pathology , 2006 .

[11]  T. Shiohara,et al.  Drug-induced Hypersensitivity Syndrome(DIHS): A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune Responses. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[12]  M. Boeckh,et al.  Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Yuan-Tsong Chen,et al.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Burastero,et al.  Viral Replication-Independent Blockade of Dendritic Cell Maturation and Interleukin-12 Production by Human Herpesvirus 6 , 2005, Journal of Virology.

[15]  J. Roujeau,et al.  Syndrome d’hypersensibilité médicamenteuse ou DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) , 2004 .

[16]  J. Roujeau,et al.  [Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)]. , 2004, Annales de dermatologie et de venereologie.

[17]  M. Tohyama,et al.  Human herpesvirus 6 and drug allergy , 2003, Current opinion in allergy and clinical immunology.

[18]  E. Mahé,et al.  Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms. , 2003, The Journal of investigative dermatology.

[19]  P. Griffiths,et al.  Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients. , 2003, Seminars in hematology.

[20]  V. Descamps,et al.  Prodynorphin gene promoter polymorphism and temporal lobe epilepsy , 2003, Annals of neurology.

[21]  Tatsuo Yamada,et al.  Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome , 2002, Annals of neurology.

[22]  M. Pirmohamed,et al.  TNFα promoter region gene polymorphisms in carbamazepine-hypersensitive patients , 2001, Neurology.

[23]  B. Crickx,et al.  Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. , 2001, Archives of dermatology.

[24]  P. Vignon,et al.  Reactivation of human herpesvirus type 6 in multiple organ failure syndrome. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  J. Roujeau,et al.  SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. , 2000, The Journal of investigative dermatology.

[26]  M. Tohyama,et al.  Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. , 1998, Archives of dermatology.

[27]  D. Descamps,et al.  Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome , 1997, The British journal of dermatology.

[28]  L. Hughes-Davies,et al.  Severe adverse cutaneous reactions to drugs. , 1995, The New England journal of medicine.

[29]  K. Akashi,et al.  Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. , 1993, The New England journal of medicine.